メーカー |
製品番号 |
製品説明 |
CAS番号 |
包装 |
価格 |
更新時間 |
購入 |
富士フイルム和光純薬株式会社(wako)
|
W01COBQP-2212 |
((2S,5R)-5-(5-Methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2h)-yl)-2,5-dihydrofuran-2-yl)methyl benzoate |
122567-97-9 |
250mg |
¥13000 |
2024-03-01 |
購入 |
富士フイルム和光純薬株式会社(wako)
|
W01COBQP-2212 |
((2S,5R)-5-(5-Methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2h)-yl)-2,5-dihydrofuran-2-yl)methyl benzoate |
122567-97-9 |
1g |
¥40000 |
2024-03-01 |
購入 |
Sigma-Aldrich Japan
|
Y0001683 |
European Pharmacopoeia (EP) Reference Standard
Stavudine impurity I European Pharmacopoeia (EP) Reference Standard |
122567-97-9 |
y0001683 |
¥28300 |
2024-03-01 |
購入 |
Sigma-Aldrich Japan
|
Y0001683 |
European Pharmacopoeia (EP) Reference Standard
[(2S,5R)-5-(5-methyl-2,4-dioxo-pyrimidin-1-yl)-2,5-dihydrofuran-2-yl]methyl benzoate European Pharmacopoeia (EP) Reference Standard |
122567-97-9 |
|
¥35200 |
2021-03-23 |
購入 |
富士フイルム和光純薬株式会社(wako)
|
W01COBQP-2212 |
((2S,5R)-5-(5-Methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2h)-yl)-2,5-dihydrofuran-2-yl)methyl benzoate |
122567-97-9 |
5g |
¥160000 |
2024-03-01 |
購入 |